Concepedia

Shaofang Wu

SW

Statistics

Publications

15

Citations

781

H-Index

14

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Tecnológico de Monterrey

Molecular Oncology (United States)

University of South Florida

Shaofang Wu is an author at The University of Texas MD Anderson Cancer Center specializing in molecular oncology, oncology, and medicine.

Publications per year

2012–2021

15

Publications

15

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

Patrick Y. Wen, Mehdi Touat, Brian M. Alexander et al. · Journal of Clinical Oncology · 2019 · 155 citations · Full text

, , +17

PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma

Shaofang Wu, Xiaolong Li, Feng Gao et al. · Neuro-Oncology · 2021 · 144 citations · Full text

, , +17

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation

Nighat Noureen, Shaofang Wu, Yingli Lv et al. · Nature Communications · 2021 · 78 citations · Full text

, , +17

Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding

Xi Wei, Shaofang Wu, Tanjing Song et al. · Proceedings of the National Academy of Sciences · 2016 · 50 citations · Full text

, , +13

<i>EGFR</i> Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma

Shaofang Wu, Feng Gao, Siyuan Zheng et al. · Clinical Cancer Research · 2019 · 50 citations · Full text

, , +17

1–5 of 15